Details for New Drug Application (NDA): 083244
✉ Email this page to a colleague
NDA 083244 describes NEMBUTAL, which is a drug marketed by Sciegen Pharms Inc, Epic Pharma Llc, and Rising, and is included in six NDAs. Additional details are available on the NEMBUTAL profile page.
The generic ingredient in NEMBUTAL is pentobarbital sodium. There are two drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the pentobarbital sodium profile page.
The generic ingredient in NEMBUTAL is pentobarbital sodium. There are two drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the pentobarbital sodium profile page.
Summary for 083244
| Tradename: | NEMBUTAL |
| Applicant: | Sciegen Pharms Inc |
| Ingredient: | pentobarbital |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 083244
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | ELIXIR;ORAL | Strength | 18.2MG/5ML | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
